Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…
New solution to improve patient treatment unveiled at the United States Association of Opioid Treatment Providers (USAOTP) Annual Conference AUSTIN,…
ASHBURN, Va., Aug. 7, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Unregulated…
Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04 Topline results expected during…
Partnership delivers innovative reimbursement options for S.T. Genesis, a medical device indicated for opioid withdrawal symptom managementBOCA RATON, Fla., Aug.…
NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical…
STOCKHOLM, SE / ACCESSWIRE / August 07, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…
- Holistic approach to measurement provides meaningful real-world impact evaluation - CLEVELAND, Aug. 06, 2024 (GLOBE NEWSWIRE) -- A new…
Tampa, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa is proud to announce that Dr. Hardeep Singh,…
SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide…